Article
Chemistry, Multidisciplinary
V. L. Rusinov, I. M. Sapozhnikova, A. A. Spasov, O. N. Chupakhin
Summary: This review summarizes the research on drugs containing an azoloazine moiety with antidiabetic activity. These drugs include azoloazines that target dipeptidyl peptidase-4, alpha-glucosidase, glycogen phosphorylase, as well as acting as PPAR gamma and GPR119 receptor agonists. The review also discusses compounds that inhibit advanced glycation.
RUSSIAN CHEMICAL BULLETIN
(2022)
Article
Biochemistry & Molecular Biology
Yatao Huang, Shuai Li, Youde Wang, Zhiwei Yan, Yachun Guo, Liying Zhang
Summary: Compound 1 is a novel brain-type glycogen phosphorylase inhibitor with protective effects on ischemic brain injury. It alleviates hypoxic-ischemic injury in astrocytes by improving cell viability and reducing LDH leakage, intracellular glucose content, and post-ischemic ROS level. It also improves cellular energy metabolism, reduces anaerobic glycolysis, and inhibits apoptosis.
Article
Green & Sustainable Science & Technology
Daniela Becker, Sandra Permann, Tamara Bakuradze, Simone Stegmueller, Elke Richling
Summary: In this study, the in vitro activity of hordatines isolated from brewer's spent grain (BSG) was investigated. The results showed that hordatines have inhibitory effects on alpha-glucosidase, but no inhibitory effect on glycogen phosphorylase alpha was observed.
Article
Chemistry, Multidisciplinary
Jaggaiah N. Gorantla, Santhi Maniganda, Salila Pengthaisong, Lukana Ngiwsara, Phannee Sawangareetrakul, Suwadee Chokchaisiri, Prasat Kittakoop, Jisnuson Svasti, James R. Ketudat Cairns
Summary: In this study, a novel method for the synthesis of alpha-D-glucosylazide was developed using mutated glycosynthase enzymes. The resulting compound was successfully conjugated with alkynes to form alpha-glucosyl triazoles, which showed potent inhibition of human lysosomal alpha-glucosidase. Notably, the inhibitory activity of some of these derivatives was more than 60 times higher than that of the commercial alpha-glucosidase inhibitor acarbose.
Article
Plant Sciences
Jose L. Ordonez, Rodrigo Perez, Andres Barriga, Ivette Seguel, Paola Guzman, Maria C. Zuniga, Carla Delporte
Summary: This study evaluated the antioxidant capacity and inhibitory activity of polyphenolic extracts from different genotypes of Ugni molinae berries. The acetonic extracts showed higher concentrations of phenolic compounds and stronger activities.
JOURNAL OF BERRY RESEARCH
(2022)
Article
Chemistry, Medicinal
Zhiwei Yan, Shuai Li, Youde Wang, Yachun Guo, Liying Zhang
Summary: A novel glycogen phosphorylase inhibitor (NGPI) was found to have significant therapeutic effects on cerebral ischemia-reperfusion injury (CIRI). NGPI effectively improved the infarct area, apoptosis of neurons, integrity of brain tissue and oxidative stress level in mice with CIRI.
FUTURE MEDICINAL CHEMISTRY
(2023)
Article
Biochemistry & Molecular Biology
Mei Gao, Hui Ma, Xiaoyu Liu, Yanhua Zhang, Liansheng Tang, Zhiyong Zheng, Xinlei Zhang, Chengshi Jiang, Lin Lin, Haiji Sun
Summary: A series of novel substituted pyrazole-fused oleanolic acid derivatives were synthesized and evaluated as selective alpha-glucosidase inhibitors. Compound 4d showed potent inhibitory activity against alpha-glucosidase and greater selectivity towards alpha-glucosidase than alpha-amylase. The in vitro cytotoxicity of compounds 4a-4f towards hepatic LO2 and HepG2 cells was also tested.
CHEMISTRY & BIODIVERSITY
(2023)
Article
Biochemistry & Molecular Biology
Sandor Kun, Rachel T. Mathomes, Tibor Docsa, Laszlo Somsak, Joseph M. Hayes
Summary: C-beta-D-glucopyranosyl azole type inhibitors have shown strong inhibitory effects on glycogen phosphorylase. The interactions between these inhibitors and the specific binding site of the enzyme, including hydrogen bonding and ion-ion interactions, are crucial for their potency. These findings have significant implications for the development of novel treatments for type 2 diabetes.
Article
Biochemistry & Molecular Biology
Peng-Fei Zheng, Zhuang Xiong, Cui-Ying Liao, Xin Zhang, Mei Feng, Xiao-Zheng Wu, Jing Lin, Lin-Sheng Lei, You-Cheng Zhang, Shao-Hua Wang, Xue-Tao Xu
Summary: This paper synthesized a series of new compounds showing potential inhibitory activities against alpha-glucosidase and alpha-amylase. Compounds 5g and 5h exhibited bifunctional inhibitory activity against these enzymes and showed no toxicity against cells.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Ayato Ikeda, Yasushi Makino, Hiroshi Matsubara
Summary: Glycogen debranching enzyme (GDE) has both 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase activities. This study analyzed the substrate specificities of these enzymes and proposed a macroscopic debranching pathway.
GLYCOCONJUGATE JOURNAL
(2022)
Article
Chemistry, Medicinal
Youde Wang, Shuai Li, Zhiwei Yan, Yachun Guo, Dongxin Yang, Liying Zhang
Summary: This study evaluated the long-term hypoglycemic effect of compound 1 in Type 2 diabetes and found that it significantly reduces blood glucose, improves oral glucose tolerance, and has positive effects. These findings provide a foundation for the development of novel glycogen phosphorylase inhibitors.
FUTURE MEDICINAL CHEMISTRY
(2022)
Article
Chemistry, Medicinal
Suksamran Chaidam, Natthiya Saehlim, Anan Athipornchai, Uthaiwan Sirion, Rungnapha Saeeng
Summary: A novel series of 1,6-bis-triazole-benzyl-alpha-glucoside derivatives were designed, synthesized, and evaluated for their inhibitory activity against alpha-glucosidase, showing potent inhibitory effects. The ester and menthol moiety were found to be crucial for the activity. Molecular docking models of potent compounds confirmed their good binding energy and interactions with amino acid residues around the enzyme's active site.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2021)
Article
Chemistry, Medicinal
Adam Sipos, Eszter Szennyes, Nikolett Eva Hajnal, Sandor Kun, Katalin E. Szabo, Karen Uray, Laszlo Somsak, Tibor Docsa, Eva Bokor
Summary: The study aimed to identify dual acting compounds that inhibit both SGLTs and GP, by extending the structure-activity relationships of SGLT2 and GP inhibitors. Several new compounds with low micromolar SGLT2 inhibitory activity were identified, but none of them inhibited GP. However, several GP inhibitor compounds were found to have low micromolar efficacy against SGLT2, with the best dual inhibitor showing potential for future antidiabetic therapy.
Article
Biochemistry & Molecular Biology
Gaurav Taneja, Chandra Prakash Gupta, Shachi Mishra, Rohit Srivastava, Neha Rahuja, Arun Kumar Rawat, Jyotsana Pandey, Anand P. Gupta, Natasha Jaiswal, Jiaur R. Gayen, Akhilesh K. Tamrakar, Arvind Kumar Srivastava, Atul Goel
Article
Multidisciplinary Sciences
Suvrat Arya, Shashi Kant Kumar, Alok Nath, Prerna Kapoor, Amita Aggarwal, Ramnath Misra, Sudhir Sinha
Article
Immunology
Farah Rahmatpanah, Sudhanshu Agrawal, Natasha Jaiswal, Hannah M. Ngyuen, Michael McClelland, Anshu Agrawal
MUCOSAL IMMUNOLOGY
(2019)
Article
Immunology
N. Jaiswal, S. Agrawal, A. Agrawal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
(2019)
Correction
Immunology
Farah Rahmatpanah, Sudhanshu Agrawal, Natasha Jaiswal, Hannah M. Nguyen, Michael McClelland, Anshu Agrawal
MUCOSAL IMMUNOLOGY
(2019)
Article
Biochemistry & Molecular Biology
Amit K. Rai, Natasha Jaiswal, Chandan K. Maurya, Aditya Sharma, Ishbal Ahmad, Shadab Ahmad, Anand P. Gupta, Jiaur R. Gayen, Akhilesh K. Tamrakar
JOURNAL OF NUTRITIONAL BIOCHEMISTRY
(2019)
Article
Endocrinology & Metabolism
N. Jaiswal, M. G. Gavin, W. J. Quinn, T. S. Luongo, R. G. Gelfer, J. A. Baur, P. M. Titchenell
MOLECULAR METABOLISM
(2019)
Article
Multidisciplinary Sciences
Shashi Kant Kumar, Suvrat Arya, Amita Aggarwal, Prerna Kapoor, Alok Nath, Ramnath Misra, Sudhir Sinha
Article
Multidisciplinary Sciences
Shashi Kant Kumar, Suvrat Arya, Ankita Singh, Ramnath Misra, Amita Aggarwal, Sudhir Sinha
Summary: The study explores the potential contribution of latent tuberculosis infection to the pathogenesis of immune-mediated inflammatory diseases in a TB endemic setting. Results suggest that persistently elevated T cell responses to Mtb antigens may contribute to disease activity in RA patients.
Article
Geriatrics & Gerontology
Natasha Jaiswal, Matthew Gavin, Emanuele Loro, Jaimarie Sostre-Colon, Paul A. Roberson, Kahealani Uehara, Nicole Rivera-Fuentes, Michael Neinast, Zoltan Arany, Scot R. Kimball, Tejvir S. Khurana, Paul M. Titchenell
Summary: This study provides novel insights into the AKT-dependent mechanisms that underlie muscle protein homeostasis, function, and metabolism in both normal physiology and disuse-induced muscle wasting.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
(2022)
Article
Multidisciplinary Sciences
Komal Singh, Rajesh Kumar, Fareha Umam, Prerna Kapoor, Sudhir Sinha, Amita Aggarwal
Summary: This study identifies B cell responses that distinguish between latent tuberculosis infection (LTBI) and active TB disease. The results suggest that the ratio of IgM to IgG antibodies, antibody binding to specific antigens, and the frequency of memory B cell subsets could indicate the protective or pathogenic immune responses following primary infection with Mycobacterium tuberculosis (Mtb).
Article
Multidisciplinary Sciences
Sudhir Sinha, Shashikant Kumar, Komal Singh, Fareha Umam, Vinita Agrawal, Amita Aggarwal, Barbara Imperiali
Summary: Styrene maleic acid lipid particles (SMALPs) were utilized to prepare and characterize membrane proteins of Mycobacterium tuberculosis (Mtb). These nanoparticles contained inner membrane protein PRA, membrane-associated proteins PstS1, LpqH and Ag85, and lipoglycan LAM. Peripheral membrane proteins Acr and PspA were excluded. Additionally, immune responses indicated that only MtM-SMALPs could induce the production of TNF-alpha.
Article
Medicine, Research & Experimental
Byungyong Ahn, Shibiao Wan, Natasha Jaiswal, Rick B. Vega, Donald E. Ayer, Paul M. Titchenell, Xianlin Han, Kyoung Jae Won, Daniel P. Kelly
Meeting Abstract
Rheumatology
S. Arya, S. Kumar, A. Nath, P. Kapoor, A. Aggarwal, R. Misra, S. Sinha
ANNALS OF THE RHEUMATIC DISEASES
(2018)
Correction
Chemistry, Multidisciplinary
Padam Singh, Shashi Kant Kumar, Vineet Kumar Maurya, Basant Kumar Mehta, Hafsa Ahmad, Anil Kumar Dwivedi, Vinita Chaturvedi, Tejender S. Thakur, Sudhir Sinha
Article
Chemistry, Medicinal
Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan
Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang
Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman
Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li
Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang
Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)
Article
Chemistry, Medicinal
Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla
Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2024)